Real-time enrollment status for this cancer clinical trial
Current Status
Recruiting
Checked: August 27, 2026 at 11:26 AM UTC
| NCT Number | NCT05797168 |
| Recruiting Status | Recruiting |
| Condition | Cancer |
| Phase | PHASE1 |
| Target Enrollment | 602 participants |
| Active Locations | 13 sites in the US |
| Sponsor | AstraZeneca |
| Last Updated on CT.gov | August 21, 2026 (6 days ago) |
As of August 27, 2026: Clinical trial NCT05797168 is currently recruiting participants. This phase1 study for cancer is actively seeking new participants at 13 locations across the United States. The study is sponsored by AstraZeneca. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05797168 is actively recruiting participants as of August 27, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 13 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05797168 was last updated 6 days ago (August 21, 2026). HelloStudys verifies this status automatically.